 |
MMC HEALTHCARE was founded in the year 1987 by the vision and dynamism of four young likeminded pharmaceutical professionals, who shared a common Alma matter viz. Madurai Medical College. MMC was started as a partnership company viz. Madras Medical Company with a small seed capital of 2 lakhs and with financial assistance from Tamilnadu Investment Corporation.
From this small beginning the company now renamed as MMC HEALTHCARE LTD has grown to become a public limited company with over 500 employees. |
 |
- To make MMC A GREAT PLACE TO WORK
- To become one among the best five pharma companies in the mind of the customer viz. Doctors, Stockist, Distributors and Chemists
- 30% growth every year.
|
 |
To follow the four way test of all the things MMCians think, say or do
- Is it the truth?
- Is it fair to all concerned?
- Will it build GOODWILL & BETTER FRIENDSHIP?
- Will it be beneficial to all concerned?
|
 |
 |
| MMC have many INNOVATIVE FIRSTS; to its credit. |
| VIVONEX |
The First Protein in Powder Form |
| SEPTIDASE FORTE |
India's First Serratiopeptidase with Micro Catalysts |
| THERMONIL |
The First Dispersible Paracetamol Paediatric Tablet |
| HEMOCARE |
India's First Haemoglobin in Powder Form |
| PILEUM |
First time in India an effective treatment for Hemorrhoids & Varicose veins |
| 1987 |
MMC Healthcare Ltd started |
| 1997 |
Converted as Public Limited Company |
| 2004 |
Chennai Plant reconstructed |
| 2005 |
MMC (HP) Pvt Ltd started |
| 2005 |
WHO GMP Approved |
| 2006 |
New training centre |
| 2006 |
PILEUM launch |
| 2007 |
New office |
| 2007 |
ISO 9001: 2000 certified |
| 2008 |
Exports |
| 2008 |
COMBit launch |
| 2009 |
ABLEto launch |
|
 |
| Trade Mark |
| All MMC products have registered Brand Names conforming to the regulations of Trade Mark registration. |
| Patent registration |
| MMC has already submitted application for patency for the products PILEUM (Application no. 2644/CHE/2007) and COMBit (Application no. 2966/CHE/2009) with all the requisite details and awaiting the sanction of patency.
For another product ABLEto the application for patency is to be submitted in the near future.
|
|
